On July 7, 2026, Amplia Therapeutics Limited, a company based in Melbourne, Australia, made an announcement regarding Mr. Brett Carter joining their Board of Directors as a non-executive director. The appointment was effective starting from July 6, 2026. Amplia Therapeutics Limited trades on the ASX under the ticker symbol ATX and on the OTCQB under the ticker symbol INNMF.